Keywords: Liver toxicity; Multiple myeloma; Pomalidomide;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Carfilzomib; Daratumumab; Elotuzumab; Pomalidomide; Refractory; Treatment; Transplant;
Keywords: AH; amyloid heavy chain; AL; amyloid light chain; ASCT; autologous stem cell transplant; ATTR; amyloid transthyretin; B-Dex; bortezomib and dexamethasone; BMDex; bortezomib plus melphalan and dexamethasone; BNP; brain natriuretic peptide; Bor; bortezomib;
Keywords: Pomalidomide; Relapsed; Refractory; Multiple myeloma; Immunomodulatory; IMiD
Pomalidomide dans les myélomes multiples
Keywords: Pomalidomide; IMID; Myélome multiple; Rechute ou réfractaire; Pomalidomide; IMID; Multiple myeloma; Relapsed or refractory;
Anti-angiogenic and anti-multiple myeloma effects of oprozomib (OPZ) alone and in combination with pomalidomide (Pom) and/or dexamethasone (Dex)
Keywords: Oprozomib; Multiple myeloma; Xenograft models; Pomalidomide; Dexamethasone;
Immunomodulatory drugs act as inhibitors of DNA methyltransferases and induce PU.1 up-regulation in myeloma cells
Keywords: Lenalidomide; Pomalidomide; DNA methyltransferase; PU.1; Multiple myeloma;
Immunomodulatory drugs in AL amyloidosis
Keywords: AL amyloidosis; Immunomodulatory drugs; Thalidomide; Lenalidomide; Pomalidomide;
Cereblon binding molecules in multiple myeloma
Keywords: Multiple myeloma; Cereblon binding molecules; IMiDs; Cereblon; Ikaros; Aiolos; Lenalidomide; Thalidomide; Pomalidomide
Le pomalidomide dans le myélome multiple
Keywords: Myélome multiple; IMiD; Pomalidomide; Immunomodulation; Multiple myeloma; IMiD; Pomalidomide; Immunomodulation;
A validated UPLC–MS/MS assay using negative ionization mode for high-throughput determination of pomalidomide in rat plasma
Keywords: Pomalidomide; UPLC–MS/MS; Pharmacokinetics; Rat plasma
Pomalidomide and Low-Dose Dexamethasone Improves Health-Related Quality of Life and Prolongs Time to Worsening in Relapsed/Refractory Patients With Multiple Myeloma Enrolled in the MM-003 Randomized Phase III Trial
Keywords: Low dose dexamethasone; Multiple myeloma; Pomalidomide; Quality of life; Relapsed/Refractory
Design and characterization of 3-azidothalidomide as a selective hydrogen sulfide probe
Keywords: Pomalidomide; Hydrogen sulfide; Azide reduction; Fluorescent probe;
Phase II study of pomalidomide in combination with prednisone in patients with myelofibrosis and significant anemia
Keywords: Myelofibrosis; Pomalidomide; Anemia;
Sensitive liquid chromatography/mass spectrometry methods for quantification of pomalidomide in mouse plasma and brain tissue
Keywords: Pomalidomide; Liquid chromatography-mass spectrometry; Mouse; Brain; Pharmacokinetics;
POMALIDOMID - nowy immunomodulujÄ
cy lek w terapii szpiczaka plazmocytowego
Keywords: pomalidomid; leki immunomodulujÄ
ce; szpiczak plazmocytowy; Pomalidomide; Immunomodulatory drugs; Multiple myeloma;
Modest activity of pomalidomide in patients with myelofibrosis and significant anemia
Keywords: Pomalidomide; Myelofibrosis; Anemia;
Isosteric analogs of lenalidomide and pomalidomide: Synthesis and biological activity
Keywords: Lenalidomide; Pomalidomide; Thalidomide; Tumor necrosis factor-α (TNF-α); Immunomodulatory; Anti-cancer;
A Phase I Study of Pomalidomide (CC-4047) in Combination with Cisplatin and Etoposide in Patients with Extensive-Stage Small-Cell Lung Cancer
Keywords: Pomalidomide; Chemotherapy; Extensive-stage small-cell lung cancer; Phase I trial; First-line therapy
Cereblon: molekularny cel leków immunomodulujÄ
cych
Keywords: cereblon; CRBN; talidomid; lenalidomid; pomalidomid; szpiczak plazmocytowy; Cereblon; CRBN; Thalidomide; Lenalidomide; Pomalidomide; Multiple myeloma;
Pomalidomide: New immunomodulatory agent with potent antiproliferative effects
Keywords: Pomalidomide; Multiple myeloma; Immunomodulatory agent
Immunomodulation as a therapeutic strategy in the treatment of multiple myeloma
Keywords: Multiple myeloma; Immunomodulation; Anticancer; Thalidomide; Lenalidomide; Pomalidomide
Mechanism of immunomodulatory drugs in multiple myeloma
Keywords: Multiple myeloma; Treatment; Immunomodulatory drugs; Thalidomide; Lenalidomide; Pomalidomide;
A phase I, dose-escalation study of pomalidomide (CC-4047) in combination with gemcitabine in metastatic pancreas cancer
Keywords: Pancreatic neoplasms; Pomalidomide; CA-19-9 antigen; Immunomodulatory therapy
Immunomodulatory agents in oncology
Keywords: Thalidomide; Lenalidomide; Pomalidomide; Multiple myeloma; Myelodysplastic syndromes